- Home
- APLT vs ECC Comparison
APLT vs ECC Comparison
Compare APLT & ECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- ECC
- Stock Information
- Founded
- APLT 2016
- ECC N/A
- Country
- APLT United States
- ECC United States
- Employees
- APLT N/A
- ECC N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- ECC
- Sector
- APLT Health Care
- ECC
- Exchange
- APLT Nasdaq
- ECC NYSE
- Market Cap
- APLT 128.0M
- ECC 1.0B
- IPO Year
- APLT 2019
- ECC N/A
- Fundamental
- Price
- APLT $0.93
- ECC $9.04
- Analyst Decision
- APLT Buy
- ECC Buy
- Analyst Count
- APLT 7
- ECC 2
- Target Price
- APLT $6.10
- ECC $11.00
- AVG Volume (30 Days)
- APLT 8.9M
- ECC 679.0K
- Earning Date
- APLT 11-07-2024
- ECC 02-22-2024
- Dividend Yield
- APLT N/A
- ECC 19.16%
- EPS Growth
- APLT N/A
- ECC 369.44
- EPS
- APLT N/A
- ECC 1.69
- Revenue
- APLT N/A
- ECC $122,654,279.00
- Revenue This Year
- APLT N/A
- ECC $36.58
- Revenue Next Year
- APLT $2,664.24
- ECC $12.88
- P/E Ratio
- APLT N/A
- ECC $5.93
- Revenue Growth
- APLT N/A
- ECC 96.41
- 52 Week Low
- APLT $0.77
- ECC $8.60
- 52 Week High
- APLT $10.62
- ECC $11.79
- Technical
- Relative Strength Index (RSI)
- APLT 18.39
- ECC 43.52
- Support Level
- APLT $0.78
- ECC $8.56
- Resistance Level
- APLT $0.90
- ECC $8.94
- Average True Range (ATR)
- APLT 0.11
- ECC 0.13
- MACD
- APLT 0.25
- ECC 0.01
- Stochastic Oscillator
- APLT 14.76
- ECC 57.98
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About ECC EAGLE POINT CREDIT CO LLC
Eagle Point Credit Co Inc is an externally managed, non-diversified closed-end management investment company.